Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics

Por Lang, Liwei, Shay, Chloe, Zhao, Xiangdong, Teng, Yong
Publicado no J Exp Clin Cancer Res (2017)

Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity

Por Teng, Yong, Cai, Yafei, Pi, Wenhu, Gao, Lixia, Shay, Chloe
Publicado no J Hematol Oncol (2017)

Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis

Por He, Leilei, Gao, Lixia, Shay, Chloe, Lang, Liwei, Lv, Fenglin, Teng, Yong
Publicado no J Exp Clin Cancer Res (2019)

Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma

Por Lang, Liwei, Shay, Chloe, Zhao, Xiangdong, Xiong, Yuanping, Wang, Xuli, Teng, Yong
Publicado no J Hematol Oncol (2019)

Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib

Por Lang, Liwei, Shay, Chloe, Xiong, Yuanping, Thakkar, Parth, Chemmalakuzhy, Ron, Wang, Xuli, Teng, Yong
Publicado no J Hematol Oncol (2018)

Nck-associated protein 1 associates with HSP90 to drive metastasis in human non-small-cell lung cancer

Por Xiong, Yuanping, He, Leilei, Shay, Chloe, Lang, Liwei, Loveless, Jenni, Yu, Jieqing, Chemmalakuzhy, Ron, Jiang, Hongqun, Liu, Manran, Teng, Yong
Publicado no J Exp Clin Cancer Res (2019)

Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib

Por Lang, Liwei, Lam, Tiffany, Chen, Alex, Jensen, Caleb, Duncan, Leslie, Kong, Feng-Chong, Kurago, Zoya B., Shay, Chloe, Teng, Yong
Publicado no Cells (2020)